Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ural Center for Biopharma Technologies
Yekaterinburg, Sverdlovsk Region, Russia
- Ownership
- Private
- Development stage
- Other
01
Overview
The entity is part of the Ural Pharmaceutical Cluster, involved in technology development, production of insulin substance, ready dosage forms, and dialysis concentrates[7]. No clinical pipeline information or trial results are published.
- Therapeutic areas
- EndocrinologyNephrologyOther
- Modalities
- Small moleculeBiologicRecombinant protein
- Industry
- Contract Manufacturing Organization
02
Partnerships
Ural Pharmaceutical ClusterMedsintez PlantSkolkovo Innovation Fund
Beyond the preview
Go deeper on Ural Center for Biopharma Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ural Center for Biopharma Technologies.